Our top pick for
US stocks
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
thedocyard Limited is a software-application business based in Australia. thedocyard shares (TDY) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. thedocyard has a trailing 12-month revenue of around $670,610. If you're looking to buy shares, check out the steps below.
How to buy shares in thedocyard
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for thedocyard . Find the share by name or ticker symbol: TDY. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until thedocyard reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of thedocyard . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Our top pick for
ETF investing
Our top pick for
Overall broker
thedocyard stock price (ASX:TDY)
Use our graph to track the performance of TDY stocks over time.thedocyard shares at a glance
Information last updated 2021-02-14.
| 52-week range | $1.165 - $1.9 |
|---|---|
| 50-day moving average | $1.3639 |
| 200-day moving average | $1.7888 |
| Target price | N/A |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.0398 |
Compare share trading platforms
The value of your investments can fall as well as rise and you may get back less than you invested. Past performance is no indication of future results.
Is it a good time to buy thedocyard stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
thedocyard financials
| Revenue TTM | $670,610 |
|---|---|
| Gross profit TTM | $425,223 |
| Return on assets TTM | -121.59% |
| Return on equity TTM | 0% |
| Profit margin | 0% |
| Book value | 0.187 |
| Market capitalisation | $2.9 million |
TTM: trailing 12 months
thedocyard share dividends
We're not expecting thedocyard to pay a dividend over the next 12 months.
Have thedocyard 's shares ever split?
thedocyard 's shares were split on a 1:10 basis on 29 November 2020. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your thedocyard shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for thedocyard shares which in turn could have impacted thedocyard 's share price.
thedocyard overview
thedocyard Limited (ASX:TDY) designs and provides a data room for mergers and acquisitions for analysts, advisors, and sellers. It serves industries, such as consumer and retail, financial institutions, healthcare, industrials, infrastructure, metals and mining, oil and gas, real estate, technology, and media and telcos. The company was founded in 2005 and is based in Sydney, Australia.
thedocyard in the news
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs comes with a higher risk of losing money rapidly due to leverage. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More guides on Finder
-
Why is the a2 Milk (A2M) share price on a high?
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
-
Why has the Bank of Queensland (BOQ) share price stumbled?
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
-
Today’s ASX top stocks: Deep Yellow (DYL ↑23.1%), Paladin Energy (PDN ↑23.0%)
The 10 biggest movers on the ASX for Wednesday 13 October 2021.
-
How to invest in the Tissue Repair IPO
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
-
How to buy Illuvium (ILV) in Australia
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
-
What is weighing down the Westpac share price today?
Westpac shares are up 43% over the past 12 months.
-
16 stocks to watch following Sydney’s “freedom day”
Airports, travel agents and pubs are set to soar post lockdown, but should share investors look beyond immediate short-term wins?
-
Why is the IAG share price on a high today?
Shares in the insurer are up just 10% in the last 12 months.
-
How to invest in the Nimy Resources IPO
Everything we know about the Nimy Resources IPO, plus information on how to buy in.
Ask an Expert
